State Street XLV vs. iShares IXJ: Here's How These Healthcare ETFs Stack Up for Investors
XLV's 0.08% expense ratio and 22.7% 1-year return outpace IXJ's global reach, but international diversification comes at a cost.
Search fresh public links, source activity, and ready-to-use post angles for Dxj.
Fresh curated links around DXJ are collected here so marketers can spot useful updates and turn timely ideas into posts faster.
Recent items include:
Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.
XLV's 0.08% expense ratio and 22.7% 1-year return outpace IXJ's global reach, but international diversification comes at a cost.
XPH delivered 57% returns over one year but swung 31% lower at its worst. IXJ offers steadier performance with higher income and $4.2 billion in assets for easier trading.
Book value fell 15.4% as spreads widened; management sees opportunities.
Traffic challenges persist, yet adjusted EBITDA climbed to $7.7 million.
Stable funding and low refinancing activity let Dynex earn attractive spreads without waiting for rate cuts.
Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.